Whats new
Whats new.
goetzpartners securities - Changing the game in lung cancer survival; Reit Buy, A$2.88 tgt (Analyst: Dr Chris Redhead)
October 30th 2023
This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.